Trial opens for accountant possibly related to Kyobo-Affinity dispute Accountant is accused of copying valuation of Kyobo's stock performed by Deloitte Anjin
Translated by Ryu Ho-joung 공개 2021-08-12 08:10:32
이 기사는 2021년 08월 12일 08:05 thebell 에 표출된 기사입니다.
The first trial has been held for an accountant who is accused of copying Deloitte Anjin’s valuation of Kyobo Life Insurance shares subject to put options, which could be the start of a long legal battle between the South Korean insurance company and its private equity investors.The Seoul Central District Court held the first trial on Tuesday for an accountant at Nexia Samduk, an accounting firm that was mandated by Affirma Capital – one of the financial investors in Kyobo – to value the insurer’s shares in 2018.
In 2012, a consortium led by Affinity Equity Partners acquired a 24% in Kyobo for about 1.21 trillion won ($1.04 billion) with a put option giving them the right to sell their holdings to Kyobo chairman Shin Chang-jae if the company fails to go public by 2015.
As Shin failed to take the company public in a specified period, the consortium exercised its put option in October 2018. A month later, Affirma Capital, another financial investor in Kyobo with a 5.33% stake, followed suit.
The Affinity consortium and Affirma Capital, formerly known as Standard Chartered Private Equity, hired accounting firms Deloitte Anjin and Nexia Samduk, respectively, to value Kyobo shares subject to put options. Deloitte Anjin valued the insurer’s stock at 409,912 per share, about twice the purchase price paid in 2012.
A prosecutor in charge of the case argued at Tuesday’s trial that the indicted accountant at Nexia Samduk exactly copied the valuation report prepared by Deloitte Anjin without proper validation, violating the country’s Certified Public Accountant Act.
The defendant’s lawyer refuted that the accountant did not copy but referred to Deloitte Anjin’s report to perform the task in a given period of time. However, when the judges asked if the accountant made any changes to the report, the lawyer answered that no changes were made.
The results of the trial are likely to have a sigificant impact on a separate case involving accountants at Deloitte Anjin and officials from the Affinity consortium.
In January this year, prosecutors indicted three accountants at Deloitte Anjin and two officials from the consortium for allegedly mispricing Kyobo’s stock price in favor of the investor group. The first trail of the case is scheduled for August 20. (Reporting by Eun-sol Lee)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- 폴라리스오피스, 클라이원트와 AI 문서 자동화 협업
- '텐스토렌트 맞손' 코아시아, 자회사 400억 투자 유치
- [Red & Blue]'변압기 관련주' 바이오스마트, 자회사 효과 '톡톡'
- [코스닥 자사주 점검]'양날의 검' 자사주, 변화의 바람 불까
- [thebell interview]"XR 서비스 3종 출시, B2C 플랫폼 구축 원년"
- SL에너지, 바이오중유 제조인허가 취득
- [동아-일동 'R&D 협업' 승부수]동아에스티, 일동 아이디언스에 250억 베팅 '2대주주' 등극
- [Company Watch]LG유플러스, 매출 대비 R&D 비율 첫 1%↑ 'AI 공략 강화'
- SC엔지니어링, M&A 매물 출회 가능성은
- 5월 기준금리 동결 유력…4분기로 밀리는 인하 시점